Latest filing published 14 Sept 2026 for Meilleure Health International Industry Group Ltd., €21k.
Based on 189 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Zhou Xuzhou in Meilleure Health International Industry Group Ltd., where the filings describe the role as chief executive. Over a trading history stretching from 3 July 2017 to 11 September 2026, the count stands at 200 filings.
Market trades split into 191 purchases (€20.0M) and 3 sales. The totals do not cover 3 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2026 to date brings 17 purchases and no sales.
In size, the median ticket on the buying side is €53k. As a share of market capitalisation, the median purchase stands at 0.033%, based on 14 purchases. 26 out of 190 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. After 189 purchases with a full 90-day history, the hit rate stands at 40% and the median 90-day move at -3.6%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 14 September 2026, reports an open-market purchase of €21k in Meilleure Health International Industry Group Ltd. Publication is fast: at least half of the trades appear on HKEX on the same day. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 200 declarations